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Parathyroidectomy: Technique for the Function
of the Parathyroid Remnant
Jordi Vidal Fortuny, MD, Samira M Sadowski, MD, Valentina Belfontali, MD, Wolfram Karenovics, MD,
Sebastien Guigard, MD, Frederic Triponez, MDThe main indications for subtotal parathyroidectomy
include hyperparathyroidism (HPT) of renal origin
(patients with renal insufficiency and patients after renal
transplantation) and primary HPT due to hyperplasia of
all 4 glands. The major surgical steps consist of bilateral
cervical exploration with identification and preservation
of both recurrent laryngeal nerves, identification of the
4 parathyroid glands, and resection of 3½ parathyroid
glands. The size of the parathyroid remnant varies
according to primary disease and operative findings.1,2
The main complications of subtotal parathyroidectomy
are recurrent laryngeal nerve palsy, persistent HPT, and
definitive or transient hypoparathyroidism. Definitive
hypoparathyroidism develops when all 4 parathyroid
glands are removed or if the parathyroid remnant is not
well perfused. Preserving a well-perfused parathyroid
remnant prevents postoperative hypoparathyroidism,
and selection of this remnant is currently based on subjec-
tive visual appreciation. To date, postoperative parathy-
roid hormone (PTH) or intraoperative PTH dosages are
the only ways to assess the function of the parathyroid
remnant.3,4 However, PTH levels reflect a global parathy-
roid function (including orthotopic, ectopic, and super-
numerary glands) and do not reflect the function of a
single parathyroid gland. Moreover, the time needed to
obtain reliable PTH dosage after parathyroidectomy
does not allow intraoperative adjustment of the extent
of surgical resection.5
Indocyanine green (ICG) angiography was initially
used in detection of macular disease.6 It has since beenis work.
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/).expanded to uses in oncologic surgery, such as to search
for sentinel lymph nodes or vascular blood flow of intes-
tinal anastomoses.7,8 Intraoperative angiography using
fluorescent ICG is a tool that can be used to assess and
predict the function of the parathyroid glands after thy-
roid resection.9-11 Some authors used ICG angiography
essentially to help identify parathyroid glands during
parathyroidectomy, but also suggested that ICG angiog-
raphy could help avoid hypoparathyroidism in 6 patients
undergoing subtotal parathyroidectomy.12 The rationale
to specifically study patients undergoing bilateral neck
exploration with subtotal parathyroidectomy was to
explore all parathyroid glands. In this situation, all glands
other than the selected remnant are removed. Subse-
quently, the PTH secretion can be attributed to the visu-
alized parathyroid remnant. This is not the case in focused
parathyroidectomy or thyroidectomy, in which more than
1 parathyroid gland is left in place, so correlation between
parathyroid perfusion, as visualized by peroperative angi-
ography and postoperative PTH levels, is not guaranteed.
We present a series of 13 patients who underwent sub-
total parathyroidectomy with ICG angiography. The aim
was to evaluate the vascularization of the parathyroid
remnant by intraoperative ICG angiography and deter-
mine whether it can predict postoperative remnant
function.METHODS
Between May 2014 and December 2015, 104 patients
underwent parathyroidectomy. Of those, 16 patients un-
derwent bilateral exploration with subtotal parathyroidec-
tomy (independent of their pathology), and peroperative
ICG angiography was performed in 13 patients (Fig. 1).
The fluorescence imaging equipment was not available
for 3 patients at the time of subtotal parathyroidectomy.
The Ethics Review Board of the University Hospitals of
Geneva approved the study.
Operations were performed by 3 experienced surgeons.
Patients underwent subtotal parathyroidectomy with
anterior cervicotomy, bilateral exploration and neuromo-
nitoring of the recurrent nerve by intermittenthttp://dx.doi.org/10.1016/j.jamcollsurg.2016.08.540
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Abbreviations and Acronyms
HPT ¼ hyperparathyroidism
ICG ¼ indocyanine green
MEN ¼ multiple endocrine neoplasia
POD ¼ postoperative day
PTH ¼ parathyroid hormone
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uous intraoperative neuromonitoring), and identification
and morphologic evaluation of all parathyroid glands. A
search for supernumerary glands was not performed
when 4 parathyroid glands were visually identified. The
search for ectopic glands was performed in and around
the thymus if an inferior parathyroid gland was missing
and a lateral-retro-esophageal search if a superior parathy-
roid gland was missing. Subtotal parathyroidectomy was
performed by applying clips onto the parathyroid glands
(Fig. 2).10,13 Special attention was paid to avoiding appli-
cation of clips onto the parathyroid hila where the vessels
are located. Occasionally, a normal looking parathyroid
gland was left in place entirely.
Criteria such as anatomic localization, vascularization,
and morphologic aspect of the glands were used to select
the gland for subtotal resection (remnant). Ideally, an infe-
rior or small gland, or a gland with no macroscopic nodule
was selected. Before resection of the parathyroid glands,
adequate perfusion of the selected remnant was controlled
by injecting 3.5 mL of ICG solution. During subtotal
parathyroidectomy, our aim is to keep a parathyroid
gland/parathyroid remnant that corresponds to the size
of 1 to 2 normal parathyroid glands. The final size of the
remnant was calculated by estimating size in 3 dimensions
and calculating its volume (height  length  width / 2).
The ICG powder (25mg, ICG Pulsion, Pulsion Medi-
cal Systems) was suspended in 10 mL of sterile water and
was injected intravenously.14 If needed, the injection was
repeated to a maximum toxic dose of 5 mg/kg/day. Indoc-
yanine green has a peak spectral absorption at about 805
nm and a peak of emission at 835 nm that can be specif-
ically detected by fluorescence equipment. After IV injec-
tion, ICG remains in the intravascular compartment
linked to plasma proteins; it has a half-life of 3.4  0.7
minutes and is removed and degraded by the liver within
15 to 20 minutes. Adverse events are rare, but vasovagal
reactions and allergies are reported in 1 in 333,000 cases.
After ICG injection, a laparoscopic system (Pinpoint
Endoscopic Fluorescence Imaging System, NOVADAQ)
was used to visualize gland perfusion. The gland is visual-
ized in green or white, depending on the viewing mode.
The more intense the color is, the better thevascularization. Selection of the remnant was based on a
nonperfused to well-perfused scale of ICG fluorescence
intensity. In our previous study on parathyroid gland
angiography after thyroidectomy, a score was used in
order to avoid early postoperative hypoparathyroidism
(ICG 0, the parathyroid is black after the injection of
ICG, indicating that the gland is not vascularized;
ICG2, the parathyroid is white, indicating that the gland
is well vascularized; and ICG1, the parathyroid is grey or
heterogeneous, suggesting that the gland is partially vascu-
larized).9 In this study on subtotal parathyroidectomy, the
aim was to avoid long-term hypoparathyroidism; howev-
er, to have low levels of PTH immediately after parathy-
roidectomy was not considered deleterious. Perfusion of
the glands and the remnant was defined by a visual grey
scale. Further, parathyroid gland blood supply was not
manipulated during localization and imaging procedures
in order to not disturb their perfusion (Fig. 3).
All patients were followed according to a standard post-
operative protocol used at our center. Hospital stay was at
least 24 hours, with regular calcium and PTH monitoring
(at least once a day). Patients received systematic calcium
supplementation with 1g of calcium and 800 IU of 25-
OH-vitamin D twice a day until the postoperative clinic
visit (postoperative day [POD] 10 to 15). Patients with
HPT of renal origin systematically received 1.25-OH
vitamin D supplementation (0.5 mg twice a day) starting
5 days before parathyroidectomy. Patients with primary
HPT received 1.25-OH vitamin D supplementation
when calcium levels dropped below 2.0 mmol/L. When
calcium was< 2.0 mmol/L (8 mg/dL) and/or when hypo-
calcemic symptoms were present, a calcium perfusion was
initiated. Values of PTH and calcium for each patient
were collected preoperatively, at day 1, day 10, and at
follow-up visit. Albumin level was always measured with
the calcium level, and results are given as “corrected cal-
cium level.” Normal values for the assays at the author’s
institution are 2.20 to 2.52 mmol/L and 1.1 to 6.8
pmol/L for calcium and PTH levels, respectively. Hypo-
calcemia was defined as a corrected calcium value < 2.0
mmol/L.
Statistical analyses were performed using GraphPad
Prism 6 software (GraphPad Software). Parametric and
nonparametric data are presented as mean  standard
deviation (SD) or median (range).RESULTS
The study design is shown in Figure 1. The indication to
perform a subtotal parathyroidectomy in the 13 patients
was HPT of renal origin in 6 patients and primary HPT
(HPT1) in 7 patients. One patient (patient 4) with renal
104 ptx
86 focused ptx 2 focused ptx + 
thyroid lobectomy
16 subtotal ptx
3 subtotal ptx for 
renal HPT without ICG 
13 subtotal ptx with 
ICG angiography
7 paƟents with HPT1 
(1 lithium-induced, 
1 MEN1, 
5 diﬀuse hyperplasia)
5 paƟents with post-
transplantaƟon 
renal HPT
1 paƟent with renal 
HPT, in dialysis
Figure 1. Design of the study. HPT, hyperparathyroidism; ICG, indocyanine green; MEN, multiple endocrine
neoplasia; Ptx, parathyroidectomy.
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procedure, and 2 had a thyroid lobectomy (patients 9
and 10). Characteristics of the patients are summarized
in Table 1.
Preoperative imaging using MIBI scintigraphy and
ultrasound was performed in every patient, except patient
1, who underwent only ultrasound because of claustro-
phobia. Intraoperatively, the 4 parathyroid glands were
visualized in every patient, and histopathologic analysis
confirmed the parathyroid origin of the resected tissue.
Undergoing subtotal parathyroidectomy procedures, 10
patients had 3½ glands removed and 3 patients had 3
glands removed. Of these resected parathyroid glands,Figure 2. Virtual parathyroid gland reduction with applied clips,
showing good perfusion of the remnant between clips during
indocyanine green angiography, as seen in red-orange on the color
scale.91.7% were hyperplastic; of those, 31.1% were nodular
as well, and 4 glands were normal (8.3%).
The mean duration of surgery was 112.8  28.9
minutes, and performing the ICG angiography increased
duration of the procedure by 3.0  2.3 minutes. The
median length of stay was 3.0 days (24 hours to 8 days
[for social reasons]). None of the patients presented
with postoperative complications such as hemorrhage or
recurrent laryngeal nerve palsy. Overall median follow-
up was 4.1 (0.8 to 13.4) months.
In all patients, the parathyroid remnant that was best
perfused was selected according to ICG angiography. In
1 patient (patient 7), the selected parathyroid remnant
was first identified by ICG angiography to be not well
perfused, so another gland was chosen for subtotal resec-
tion, after additional ICG control.
Two patients (patients 5 and 8) needed IV calcium sup-
plementation according to our protocol: 1 patient with
HPT1 associated with multiple endocrine neoplasia type
1 (MEN1) was discharged 24 hours after surgery and
had to be readmitted for paresthesia with hypocalcemia
at 1.81 mmol/L; the other patient with renal HPT expe-
rienced asymptomatic hypocalcemia in the immediate
postoperative setting. For both patients, treatment by
IV calcium infusion was stopped after 48 hours.
At postoperative day (POD) 1, 4 patients presented a
low PTH level (<1.1 pmol/L). At POD 10, PTH was
measurable in all patients, indicating that the parathyroid
remnant was well functioning, except in 1 patient who
had a PTH value of 0.9 pmol/L, with a hypercalcemia
of 2.84 mmol/L (patient 3). At follow-up, corrected cal-
cium levels and PTH levels were in the normal range
e46 Fortuny et al Indocyanine Green Angiography in Parathyroidectomy J Am Coll Surgfor all patients, according to their pathology (Table 1).
Furthermore, at last follow-up, PTH levels decreased
70.7%  22.5% compared with preoperative levels.DISCUSSION
This study shows that ICG angiography is feasible in
patients undergoing subtotal parathyroidectomy and
that parathyroid remnant perfusion correlates with post-
operative gland function. At follow-up, corrected calcium
levels were within normal range (all patients recovered
from their HPT) and none presented with
hypoparathyroidism.
Primary HPT is due to a single adenoma in 80% to
85% of patients and is multiglandular (either multiple
adenoma or diffuse hyperplasia) in 15% to 20% of theFigure 3. Indocyanine green angiography of (a) a nonperfused, (b) a mo
c: Normal views. Circles indicate parathyroid gland. a’, b’, c’: Black an
combined normal and near infra-red views.patients. In HPT1 associated with MEN1 and renal
HPT, all parathyroid glands are usually involved.15,16
A search for all 4 parathyroid glands is generally recom-
mended for patients with sporadic HPT1 and negative or
discordant imaging, with lithium-induced HPT1, with
HPT1 associated with MEN1, and with renal HPT. Sub-
total parathyroidectomy or total parathyroidectomy with
or without auto-transplantation is usually recommended
for patients with diffusely enlarged parathyroid glands
in HPT1 and in renal HPT.17,18 In our center, we perform
subtotal parathyroidectomy for all patients having diffuse
parathyroid disease. Usually, the most normal looking
gland is left in place or used for subtotal resection; the
other 3 glands are resected. Visual evaluation of the
remnant is based on the coloration and morphology of
the gland, which is a subjective decision.derately perfused, and (c) a well perfused parathyroid remnant. a, b,
d white near infra-red views. Arrows indicate remnant. a”, b”, c”:
Table 1. Patient Characteristics with Pathology and Laboratory Results
Pt.
no. Age, y Sex Pathology
Preoperative Postoperative
Gland in
place*
Weight of
gland in
place, gy
Weight of
resected
glands, gCac PTH
POD1 POD10 Follow up
Cac PTH Cac PTH Cac PTH
1 46 M Renal HPT e Post
transplantation 1990
2.49 33.9 2.35 1.3 2.19 7.6 2.36 4.7 0/0.5/0/0 0.049 1.586
2 70 M Renal HPTe Post
transplantation 2012
2.66 9.6 2.53 0.9 2.84 0.9 2.23 3.0 0/0/0.5/0 0.016 1.755
3 54 F Goiter þ renal HPTe Post
transplantation 2013
2.99 13.3 2.29 0.9 2.36 1.6 2.34 3.5 0/0.5/0/0 0.038 0.389
4 38 F Renal HPT e Post
transplantation 1999
2.58 46.4 2.54 1.5 2.55 1.2 2.19 13.6 0/0/0/0.5 0.036 1.990
5 65 F Renal HPT e Post
transplantation 2001
2.72 7.3 2.39 1.2 2.73 1.8 2.36 4.7 0/0/0.5/0 0.032 2.550
6 62 M HPT 2 under dialysis 2.29 106.0 1.93 8.0 2.17 11.0 2.24 3 0.5/0/0/0 0.025 3.080
7 24 F HPT1 MEN1 2.57 30.9 2.24 0.9 1.96 4.4 2.07 5.8 0/0/0/0.5 0.015 3.790
8 67 F HPT 1 e Lithium 2.72 17.6 2.39 2.5 2.27 4.0 2.34 4.4 0.5/0/0/0 0.053 0.581
9 62 F Goiter þ HPT 1 2.53 6.3 2.15 3.0 2.40 4.0 2.27 4 0/1/0/0 0.018 0.410
10 63 F Goiter þ HPT 1 2.56 8.0 2.11 2.0 2.12 5.0 2.38 4.25 1/0/0/0 0.009 1.130
11 50 F HPT 1 2.65 25.3 2.41 10.0 2.53 12.0 2.41 12 0/0/0/1 0.010 0.468
12 70 F HPT 1 2.55 13.0 2.39 4.0 2.34 8.0 2.45 9 0.5/0/0/0 0.042 0.639
13 63 F HPT 1 2.54 8.162 2.37 1.0 2.32 3.0 2.32 6.8 0/0/0/0.5 0.018 0.216
Totalz 56.5  13.7 2.60 
0.16
17.6 [6.3
e106]
2.31 
0.17
1.5 [0.9
e10]
2.37 
0.25
4.96 
3.65
2.34 
0.13
5.91 
3.61
0.028 
0.015
1.430 
1.15
*Parathyroid gland left in place: 0.5 corresponds to a subtotal resection, 1 when an entire, normal-looking parathyroid gland was left in place. Data show right superior/right inferior/left superior/left
inferior.
y(Height  length  width)/2.
zTotal shown in mean  SD or median [range].
Cac, corrected calcium level in mmol/L; F, female; HPT1, primary hyperparathyroidism; HPT 2, secondary hyperparathyroidism; M, male; MEN1, multiple endocrine neoplasia type 1; POD,
postoperative day; PTH, parathyroid hormone level in pmol/L.
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e48 Fortuny et al Indocyanine Green Angiography in Parathyroidectomy J Am Coll SurgThe aim of using ICG angiography during subtotal
parathyroidectomy is to decrease the risk of permanent
postoperative hypoparathyroidism, and ICG angiography
confirms that the parathyroid remnant is well perfused,
and therefore functional, before proceeding with resection
of the other parathyroid glands. If a parathyroid gland
that is not well perfused is identified by ICG angiography,
another gland can be chosen, which happened in 1 patient
in this series. Therefore, surgeons can adapt their decision
intraoperatively based on the ICG angiography results,
which is a personalized and reproducible evaluation of
the vascularization and, therefore, the function of each
parathyroid gland.
Intraoperative and early postoperative measurement of
PTH is a reliable indicator of global parathyroid function.
According to the literature, it is used to evaluate the
chance of cure in HPT3 and to evaluate the risk of post-
operative hypoparathyroidism after thyroidectomy.19-21
However, PTH values cannot be interpreted as the func-
tion of an individual parathyroid gland, and usually the
results are obtained too late for the surgeon to adapt the
surgical procedure. Moreover, one of the main indications
of subtotal parathyroidectomy is HPT of renal origin. In
this situation, intraoperative PTH decreases more slowly
and later than in patients with normal renal function.22
In this study, 4 patients had low PTH levels on POD1
despite a well-vascularized remnant. This immediate
postoperative low PTH can be explained by persistent
hypercalcemia (due to HPT itself and to the added sup-
plementation, according to our post-parathyroidectomy
protocol), parathyroid stunning (dormant glands stunned
by long-standing hypercalcemia), or less intensely
perfused glands shown with ICG (nonetheless, the best
perfused remnant was chosen). This might explain the
low PTH secretion in the immediate postoperative
setting, followed by a quick recuperation. At POD10,
only 1 patient had a low PTH level, but this patient pre-
sented with hypercalcemia (patient 3). This can explain
the suppressed PTH level, and the hypercalcemia in this
patient was probably due to excessive calcium and vitamin
D supplementation. This patient had normal calcium
(2.24 mmol/L) and PTH levels (3.0 pmol/L) at 4.1
months of follow-up. Many patients will develop hypocal-
cemia after parathyroidectomy in renal HPT, and in some
cases of HPT1.23 Our ICG angiography technique dem-
onstrates that a well-perfused parathyroid remnant will
produce measurable PTH levels and therefore avoid
long-term postoperative hypoparathyroidism. However,
it does not prevent immediate postoperative hypocalce-
mia in patients who have severe bone disease and there-
fore are at risk of developing a hungry bone syndrome
after parathyroidectomy.Our study has some limitations. The laparoscopic sys-
tem used in this study is expensive. However, ICG angi-
ography equipment can be used and shared by
departments for different procedures (visceral, plastic, car-
diovascular, and gynecologic surgery), which may
decrease the cost per patient. On the other hand, ICG
dye is not expensive. The second limitation is the residual
fluorescence after the first ICG injection. This renders
evaluation after subsequent injections more difficult,
although not impossible. To avoid this problem, we apply
clips on more than 1 parathyroid gland before ICG angi-
ography and then evaluate the perfusion of those “virtual”
remnants (the parathyroid tissue that will be left in place
after subtotal resection). Subsequently, the best remnant
is chosen before resecting any parathyroid tissue.13
Further, ICG angiography fluorescence quantification is
scored subjectively by the surgeons, which could explain
the discrepancy in quantifying the intensity of fluores-
cence. Nevertheless, the visual difference between a non-
perfused gland and a well-perfused gland is clearly
apparent in our study (Fig. 3). New technical imaging
solutions are currently being developed to help surgeons
quantify the intensity of fluorescence by ICG. The func-
tion of a parathyroid remnant and its capacity to produce
different levels of PTH in the same metabolic conditions
like calcium, phosphate, and vitamin D levels, depends on
3 main characteristics: size of the remnant, underlying
primary disease, and perfusion of the remnant. A larger
remnant will produce more PTH, a remnant in a patient
with terminal renal insufficiency will probably produce
more PTH than the same size remnant in a patient
with sporadic HPT and lastly, a better perfused remnant
will produce more PTH. In this preliminary study on 13
patients with HPT of different origin, it was not possible
to correlate the quality of the perfusion with the postop-
erative level of PTH because of the small sample size.
However, developing a reliable perfusion scale that could
be correlated to postoperative PTH levels is an area for
future research.
Our previous study results in 36 patients undergoing
thyroidectomy showed a measurable PTH on POD1 in
all patients demonstrating at least one well-vascularized
parathyroid gland (no patient developed hypoparathy-
roidism).9 However, in this previous study, we did not
identify all parathyroid glands during the surgical proced-
ure, so it was impossible to guarantee that postoperative
parathyroid function was due to the identified well-
vascularized parathyroid gland. In this study, all parathy-
roid glands were identified and 1 remnant was left in place
in each patient. Therefore, we conclude that postoperative
parathyroid function truly reflects remnant function as
evaluated by ICG.
Vol. 223, No. 5, November 2016 Fortuny et al Indocyanine Green Angiography in Parathyroidectomy e49CONCLUSIONS
Our findings suggest a good correlation between parathy-
roid gland perfusion and postoperative parathyroid func-
tion with production of PTH. If these results are validated
by future studies, this technique could be used to verify
parathyroid vascularization and predict good parathyroid
function during parathyroid surgery. This adds a real time
tool to assess parathyroid remnant function and assists the
surgeon in the intraoperative decision-making process.
Finally, our study results might represent a proof of
concept of this new technique applicable in thyroid sur-
gery, to predict postoperative parathyroid function.Author Contributions
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